These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10094880)

  • 1. Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors.
    Lane AH; Lee MM; Fuller AF; Kehas DJ; Donahoe PK; MacLaughlin DT
    Gynecol Oncol; 1999 Apr; 73(1):51-5. PubMed ID: 10094880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities.
    Gustafson ML; Lee MM; Asmundson L; MacLaughlin DT; Donahoe PK
    J Pediatr Surg; 1993 Mar; 28(3):439-44. PubMed ID: 8468660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.
    Gustafson ML; Lee MM; Scully RE; Moncure AC; Hirakawa T; Goodman A; Muntz HG; Donahoe PK; MacLaughlin DT; Fuller AF
    N Engl J Med; 1992 Feb; 326(7):466-71. PubMed ID: 1732773
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on the anti-müllerian hormone served as a marker for granulosa cell tumor of ovary].
    Long W; Wang W; Rey R
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):356-8. PubMed ID: 11776178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadoblastoma: immunohistochemical localization of Müllerian-inhibiting substance, inhibin, WT-1, and p53.
    Hussong J; Crussi FG; Chou PM
    Mod Pathol; 1997 Nov; 10(11):1101-5. PubMed ID: 9388060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors.
    Rey R; Sabourin JC; Venara M; Long WQ; Jaubert F; Zeller WP; Duvillard P; Chemes H; Bidart JM
    Hum Pathol; 2000 Oct; 31(10):1202-8. PubMed ID: 11070112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.
    Lee MM; Donahoe PK; Hasegawa T; Silverman B; Crist GB; Best S; Hasegawa Y; Noto RA; Schoenfeld D; MacLaughlin DT
    J Clin Endocrinol Metab; 1996 Feb; 81(2):571-6. PubMed ID: 8636269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance.
    Seifer DB; Maclaughlin DT
    Fertil Steril; 2007 Sep; 88(3):539-46. PubMed ID: 17559842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive inhibin, müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors.
    Silverman LA; Gitelman SE
    J Pediatr; 1996 Dec; 129(6):918-21. PubMed ID: 8969738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos.
    Meyers-Wallen VN; MacLaughlin D; Palmer V; Donahoe PK
    Mol Reprod Dev; 1994 Sep; 39(1):1-7. PubMed ID: 7999353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody against avian müllerian inhibiting substance (MIS) recognizes MIS on rat müllerian duct and human tumor cells.
    Wang JJ; Teng CS
    Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):267-75. PubMed ID: 2484046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo.
    Stephen AE; Pearsall LA; Christian BP; Donahoe PK; Vacanti JP; MacLaughlin DT
    Clin Cancer Res; 2002 Aug; 8(8):2640-6. PubMed ID: 12171896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulosa cell tumor of the ovary.
    Schumer ST; Cannistra SA
    J Clin Oncol; 2003 Mar; 21(6):1180-9. PubMed ID: 12637488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
    Anttonen M; Unkila-Kallio L; Leminen A; Butzow R; Heikinheimo M
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6529-35. PubMed ID: 16159935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal antiproliferative effect of recombinant müllerian inhibiting substance on gynecological tumor cell lines and tumor explants.
    Wallen JW; Cate RL; Kiefer DM; Riemen MW; Martinez D; Hoffman RM; Donahoe PK; Von Hoff DD; Pepinsky B; Oliff A
    Cancer Res; 1989 Apr; 49(8):2005-11. PubMed ID: 2702642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay.
    Long WQ; Ranchin V; Pautier P; Belville C; Denizot P; Cailla H; Lhommé C; Picard JY; Bidart JM; Rey R
    J Clin Endocrinol Metab; 2000 Feb; 85(2):540-4. PubMed ID: 10690852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization.
    Misra M; MacLaughlin DT; Donahoe PK; Lee MM
    J Clin Endocrinol Metab; 2003 Feb; 88(2):787-92. PubMed ID: 12574214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Müllerian inhibiting substance in reproduction and cancer.
    Donahoe PK
    Mol Reprod Dev; 1992 Jun; 32(2):168-72. PubMed ID: 1637555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.
    Chang HL; Pahlavan N; Halpern EF; MacLaughlin DT
    Gynecol Oncol; 2009 Jul; 114(1):57-60. PubMed ID: 19359032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.